About UICC

161101_2016WCC_WEB-617.jpg

The Board of Directors, elected on 1 November 2016 by the General Assembly in Paris, France will serve until December 2018.

Between assemblies, a board of 17 directors, elected by the General Assembly, act as the governance body of UICC.

 

 

The following individuals have been elected:

PRESIDENT

BOD16-18_Sanchia_Aranda_web.jpg
Sanchia Aranda
(Australia)
Biography
 
   

PRESIDENT-ELECT

IMMEDIATE-PAST PRESIDENT

BOD16-18_Princess_Dina_Mired_web.jpg
BOD16-18_Tezer_Kutluk_web.jpg
HRH Princess Dina Mired
(Jordan)
Biography
Tezer Kutluk
(Turkey)
Biography

 

BOARD MEMBERS

BOD16-18_Benjamin_Anderson_web.jpg

Benjamin O. Anderson (United States)

Since 1994, I have been a joint faculty member at the Fred Hutchinson Cancer Research Center in Seattle and the University of Washington in the Departments of Surgery and Global Health Medicine, where I care for women with breast cancer and breast health issues. As a practicing surgeon, I keep attuned to current issues in cancer diagnostics and treatment.

Since 1998, I have served on the National Comprehensive Cancer Network (NCCN) breast cancer panel, which develops treatment guidelines for breast cancer in the United States, and am now vice-chair of that internationally recognised guideline panel.

My experience and perspective in global oncology have value for the UICC Board of Directors. In 1995, I started in cancer advocacy as principle scientist for the National Breast Cancer Coalition (NBCC) advocacy training course ‘Project LEAD’. Since then, I have devoted my research career to the study of best practices in global oncology. In 2002, I founded the Breast Health Global Initiative (BHGI), which pioneered the development of comprehensive resource-stratified, evidence-based guidelines for breast care in LMICs.

Having been involved with UICC since 2003, I am now completing my second two-year term on the UICC Board of Directors.

As recipient of the 2011 American Society of Clinical Oncology (ASCO) Partners in Progress Award, and the 2013 National Consortium of Breast Centers (NCBC) Inspiration Award, I respectfully request your support in continuing to work with UICC as a board member in our dedicated team efforts to improve the quality and effectiveness of cancer care around the globe. 


BOD16-18_Heather_Bryant_web.jpg

Heather Bryant (Canada)

As Vice-President, Cancer Control at the Canadian Partnership Against Cancer, I am responsible for leadership of the population health, clinical, and person-centred experience portfolios in Canada.

My team and I have also worked with partners across Canada to develop the first pan-Canadian reports on the functioning of the cancer control system. This work requires stakeholder engagement with patients, health ministries, experts and cancer control leaders along with deep cancer control expertise; similar skills are needed within UICC.

Other national roles have included being the inaugural chair of the Institute Advisory Board for Cancer for the Canadian Institutes for Health Research, the National Colorectal Cancer Screening Network, and participation in many other national committees.

I have been involved in international cancer control activities for many years, including service on the Board of the International Association of Cancer Registries and as Canada’s representative on the governing council of the International Agency for Research in Cancer.

I am currently the Chair of the Programme Board of the International Cancer Benchmarking Program, which is hosted by Cancer Research UK and which works to develop and explain differences in international cancer survival
rates. I believe that this background, coupled with the UICC experience described above, can be put to good service as a Board member continuing to move UICC forward. 


Maira Caleffi (Brazil)

BOD16-18_Maira_Caleffi_web.jpg

With 30 years of experience as a dedicated breast surgeon, I am deeply involved in population-based research related to breast cancer diagnosis, access and treatment for low- and middle-income patients.

In my career, I have also become deeply passionate about advocating for the rights of Brazilian patients and their access to quality treatment and services. That passion has expanded to include all patients in Latin America and, through my work with UICC, to all patients worldwide.

My clinical experience together with my involvement in patient advocacy gives me a unique perspective that I bring to the UICC Board.

I have spent my career as a surgeon trying to do what is right and best for patients, yet I have found myself in an environment in which cancer is not prioritised. This has motivated me to do everything I can to create change.

As voluntary President of Femama, I work to lead a group of cancer patient associations to whom the organisation provides training and information while also working to influencing the development and implementation of public policies. As Founder and President-Elect (2018/19) of the Unión Latinoamericana Contra el Cáncer de la Mujer (ULACCAM), I am working to draw attention to the differences and singularities in healthcare among Latin American countries.

I believe this background can contribute to UICC’s efforts to identify new strategies for engaging stakeholders to work together toward finding solutions for our patients. 


Eduardo Cazap (Argentina)

BOD16-18_Eduardo_Cazap_web.jpg

One of the topics of my interest is the proactive promotion of North-South, South-North and South-South relationships.

Another important matter at the international level is the integration of governments working together with civil society in the planning and implementation of cancer control actions.

In accordance with the main avenues of work approved by previous Boards, defined as Convening, Capacity Building, Advocacy, Membership, Partners and Resources, I believe that I can collaborate in various areas following the preceding criteria.

In Convening, I could help in promoting networking activities between UICC and our members and partners. Through my contacts with organisations and cancer control colleagues in different parts of the world I will be able to work in this aspect.

With respect to Capacity Building, I have previously worked with GETI, GAPRI, CCI, GICR and other programmes so I will be able to cooperate with these programmes.

Naturally, I will be happy to help in Membership as I did in the past, working in the improvement of our membership and the maintenance of current members with close contacts, mainly in Latin America, Europe and the US.

In a similar way, I can work in the Partners and Resources activities.

If I have the opportunity to be a member of the Board again, I will try to combine my previous experience, helping to maintain the institutional memory of our organisation together with my aspiration to consolidate UICC as THE global leader in cancer control.


Sally Cowal (United States)

BOD16-18_Sally_Cowal_web.jpg

I have nearly 50 years of global experience as a United States Diplomat and Ambassador, as a high-level United Nations Official, as the CEO of a non-profit youth exchange organisation (Youth for Understanding), as the chief development officer for a non-profit global health organisation with a US$600 million per year budget (Population Services International) and currently as the senior Vice President for International Cancer Control at the American Cancer Society, the world’s largest voluntary health organisation.

Additionally, I have extensive experience in non-profit governance as a member of the Boards of DePauw University, the Tinker Foundation, the American Diplomacy Foundation, and Grounds For Health. I chair the Audit Committee at the Tinker Foundation. I understand a Board’s fiduciary and governance responsibilities and the distinction between Board and Staff leadership.

I speak fluent Spanish and intermediate French. I have experience in Private Public Partnerships and have worked directly with the private sector and governments and civil society in Asia, Africa, the Middle East, Latin America and the Caribbean. I believe that UICC needs to embrace and encourage an “all of society” approach to be effective in the fight against the rising tide of cancer. My experience in all of the sectors could be of help in guiding UICC’s strategic plan over the next five years. 


Anil D'Cruz (India)

BOD16-18_Anil_D'Cruz_web.jpg

I am currently the Director at Tata Memorial Hospital in Mumbai, India, the largest and one of the oldest comprehensive cancer centres in the world. I have been engaged in the field of cancer control at the national level in India for close to thirty years. I have delivered over 350 lectures across the globe and authored more than 200 peer-reviewed publications. I hold numerous leadership positions both nationally and internationally, on boards of directors, governing councils and executive committees of various hospitals, research centres, governmental organisations, cancer care organisations, advocacy groups and professional bodies. In addition, I have served on many of the pivotal committees of the the UICC Board, including Governance, Finance, Membership, Congress and World Cancer Leaders’ Summit. I am Co-chair of the 2016 World Cancer Congress Programme Committee and was on the organising committee of the 2014 World Cancer Congress in Melbourne.

This unique position of being a clinician, researcher, administrator and a leader with a clear understanding of the functioning of UICC, gives me the advantage of bringing the right blend of science and action into the fight on cancer control, identify priority areas that need attention and the potential solutions that need to be worked on.

As a current member of the Board of Directors of UICC, I am actively involved with many ongoing projects and a further two years would give me a chance to see them to completion. 


Jeff Dunn (Australia)

BOD16-18_Jeff_Dunn_web.jpg

I am CEO of Cancer Council Queensland and have worked with UICC for nearly 30 years.

I currently hold Professorial appointments with the University of Southern Queensland Institute for Resilient Regions and the Griffith University School of Medicine and University of Queensland’s School of Social Science. I have a central focus on the social and behavioural aspects of cancer control, spanning across the continuum of research, prevention, early detection, supportive care and quality of life.

I am actively involved in research in this field and have dedicated my career to the development of novel supportive care strategies that underpin cancer prevention and improve community awareness of the disease.

Currently, I serve as:

  • CEO of Cancer Council Queensland (CCQ)
  • Secretary and Director of the International Psycho- Oncology Society (IPOS)
  • Immediate-past President of the Asia Pacific Organization for Cancer Prevention
  • Chair, Asia Pacific Cancer Society Training Grants Program (APCASOT)
  • Chair, Reach to Recovery International Board of Management

My distinguished service to cancer control includes policy, programme development, advocacy and translation
of research into community-based collaborations and interventions.

I was appointed an Officer in the Order of Australia in June 2014 for distinguished service to medical administration through leadership roles with cancer control organisations and to the promotion of innovative and integrated cancer care programmes.


Nick Grant (United Kingdom)

BOD16-18_Nick_Grant_web.jpg

My career has given me experience in commercial and non- profit organisations in a number of sectors. I have spent most of my career in strategy consulting, working with healthcare and lifescience organisations in over 25 countries.

I have also worked in the international NGO sector, developing a new global governance model at Save the Children and supporting local programmes in Colombia and the Philippines, in particular.

Since joining Cancer Research UK, I have led the development of strategies across all different parts of the organisation, including fundraising, research funding and policy. In particular, I have been an advocate for greater investment in early detection and prevention. I have served on the Executive Board for the last 18 months, most recently as Executive Director of International Partnerships.

I would bring to the UICC Board a strategic mindset, but also a deeply facilitative approach to working with individuals and with organisations. I have been fortunate in recent years to have worked with cancer organisations in many countries around the world, enabling me to understand the differences in local context, and the opportunities to share understanding and build productive partnerships.

I strongly believe in the potential for new models of international collaboration, particularly in research, and see UICC as a powerful platform to make this a reality.


BOD16-18_Mhamed_Harif_web.jpg

Mhamed Harif (Morocco)

In my country and throughout the experience of the French African paediatric oncology group, I have been involved in capacity building in Africa. We have been able to put in place pilot units of paediatric oncology in most French-speaking African countries and show that with appropriate support, cancer care and survival is possible, even in very poor settings. 

 

 

 

 


Hussein Khaled (Egypt)

BOD16-18_Hussein_Khaled_web.jpg

I am a professor emeritus of medical oncology at the National Cancer Institute, Cairo University. I started there as a resident in 1977; then in 2002 I served as the dean of this great and comprehensive institute for six years. Thereafter, I was appointed Vice President of Cairo University (2008 – 2011) and then Minister of higher education of Egypt (2012).

I have been engaged in many activities related to the profession of cancer control on national level, such as secretary general of the Egyptian foundation for cancer research, head of the council of the Egyptian medical oncology fellowship, head of the committee of oncology university staff promotion and the editor in-chief of journal of advanced research (the official journal of Cairo University). In 2015, I won the State Recognition Award for advanced technological sciences in the medical field.

Regionally and internationally, I served as the Assistant Secretary General of the Arab Medical Association Against Cancer for four years, the national representative of the European Society of Medical Oncology (ESMO) for Egypt and North Africa for six years (2000-2006), and I am the current president of the South and East Mediterranean College of Oncology. I am also a member of many international societies including ESMO, ASCO, INCTR, and the lymphoma group in the EORTC. I was also a member of the editorial board of the Annals of Oncology, the ESMO official journal (2006-2012).

My research activities are focused mainly on bladder cancer, breast cancer, and malignant lymphomas, with more than 150 national and international publications (total impact factor of 470; total citations of 1741, and h-index of 22 as of December, 2015). 


Anne Lee (Hong Kong S.A.R., China)

BOD16-18_Anne_Lee_web.jpg

I believe that I am a good candidate because I can make substantial contribution to UICC through:

  • My extensive international network with oncologists – as an internationally renowned clinical oncologist, I am well-connected with influential oncologists worldwide and I can engage them in contributing to UICC initiatives.
  • My passion to promote global health – I am now leading a project for International Atomic Energy Agency to improve outcomes for nasopharyngeal cancer in low- middle income countries.
  • My dedication and close collaboration with UICC –
    • I am the Coordinator of the Global Advisory Group for UICC, working with global experts to develop TNM staging and chairpersons of National Cancer Staging Committee to promote universal application.
    • I have facilitated the launching of the World Cancer Atlas (Chinese Version) in Hong Kong and organised symposiums with participation of regional policy makers to advocate cancer control planning in Asia.
  • My experience in building a new cancer centre in China, with the mission of stimulating health reforms in China, providing state-of-the-art cancer services (including palliative care), and training Chinese professionals to international standard.
  • My resourcefulness as shown by the successful initiation of a charity program that engage pharmaceutical companies to donate expensive cancer drugs to patients in need.
  • My experience (as a Member of Cancer Coordinating Committee, Hong Kong SAR) in advising government policy maker to formulate cancer control strategies.
  • My knowledge and expertise in cancer services in public hospitals.
  • My knowledge and expertise in cancer education of clinical oncologists, medical students, and the public. 

Gilbert Lenoir (France)

BOD16-18_Gilbert_Lenoir_web.jpg

I have dedicated my entire career to cancer research, as a scientist at the International Agency for Research on Cancer (IARC – WHO Lyon, France) and then as a professor at the medical school.

In 2000, I was appointed Deputy Director in charge of research at the Institute Gustave Roussy, Villejuif, one of the largest comprehensive cancer centres in Europe.

Since 2010, I have been in charge of the Paris bio cluster programme, Cancer Campus.

I am the author of more than 400 articles in cancer genetics, epidemiological and translational research. My experience has been mainly in research involving international collaborations: basic and translational, epidemiology always implicating public health issues such as those on Burkitt’s lymphoma in Central and North Africa and on nasopharyngeal carcinoma in South East Asia. My basic research also required international collaborations mainly between European and North American teams.

In 1985, I initiated large international projects aimed at studying genetic susceptibility to cancer. As director of research at Gustave Roussy, I mainly launched several European projects on translational research.

I have been a Board member (1998-2016) and Past President (2010-2012) of the ‘Ligue Française contre le Cancer’ (the major French cancer charity). In this position, I reinforced our participation with UICC and the European Cancer Leagues association.

We also created the ‘Alliance des Ligues francophones, Africaines et Méditerranéennes’ (ALIAM). We have proposed to host the 2016 UICC World Cancer Congress.

I have been part of the Board of UICC since 2012. 


Saunthari Somasundaram (Malaysia)

BOD16-18_Saunthari_Somasundaram_web.jpg

In my current tenure as part of the UICC Board of Directors, the National Cancer Society of Malaysia (NCSM) has created greater visibility of UICC within the region via our existing network, as well as new networks that we continuously build.

I have also championed for the interest of low-resource countries, resulting in more commitment in capacity building within these regions.

The accumulation of clinical, educational, operations and counselling skills, as well as the differing experiences, have provided me with a comprehensive picture of the benefits, challenges, needs and gaps of cancer control in ASEAN.

Currently, apart from being the President and Medical Director of NCSM, I hold positions nationally in the Malaysian Women for Tobacco Control and Health (MyWatch), Malaysian Council for Tobacco Control and NCD Alliance Malaysia.

Internationally, I sit on the Boards of UICC, International Cancer Information Service (ICISG) and ASEAN NCD Alliance. These roles also lead me to a broader view of the main issues related to cancer.

The NCSM’s excellent relationships with national and worldwide health agencies have also ensured that we work collaboratively and in partnership to strengthen the region’s commitment towards cancer control. We will also host World Cancer Congress in 2018.

In conclusion, my experiences, ongoing initiatives, passion and drive continuously broadens my vision of how we can minimise the threat of cancer, and I believe that sharing – as well as learning – from the UICC Board will move us forward in the battle against cancer.


Ann Steyn (South Africa)

BOD16-18_Ann_Steyn_web.jpg

My experience over the past 20 years as a cancer survivor and committed volunteer, working both locally and internationally on various cancer forums, has given me exposure to grass roots realities that affect cancer patients.

As a member of the Reach to Recovery International (RRI) Board, I was instrumental in establishing RRI groups in 14 African countries. Today, these groups support cancer patients, run cancer outreach programmes and advocate for suitable cancer health programmes.

I was invited to serve on the support care task team of the Breast Health Global Initiative that developed policy guidelines for the management of breast cancer in low- and medium-income countries.

As President of RRI (2007-2013), I led the team that organised the successful RRI Conference in Cape Town.
As a direct result of this conference, a South African Breast Cancer Prevention and Control Policy development process was initiated.

During the past 20 years, I have interacted with many people from all walks of life. I have worked as an ordinary member of various teams and also led teams.

As a member of the UICC Board, I would be able to voice the needs of people living with cancer, particularly in Africa and more particularly in Sub-Saharan Africa. I am passionate, committed and dedicated to playing a role in building capacity of cancer leadership in this region and to ensure improvement in services delivery in developing countries.

I care for people and would consider it a great honour to represent countless global cancer survivors on a board such as UICC.